We are live on
!
Find out more
PMEF
Point72 Middle East FZE Portfolio holdings
AUM
$3.38B
1-Year Est. Return
14.09%
This Fund
S&P 500
This Quarter
Est. Return
+9.18%
1 Year Est. Return
+14.09%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.28B
AUM Growth
–
Cap. Flow
+$2.29B
Cap. Flow
% of AUM
100.2%
Top 10 Holdings %
Top 10 Hldgs %
13.25%
Holding
1,846
New
1,844
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
S&P Global
SPGI
|
+$16.3M |
| 2 |
Advanced Micro Devices
AMD
|
+$15.6M |
| 3 |
American International
AIG
|
+$14.1M |
| 4 |
Tesla
TSLA
|
+$13M |
| 5 |
Merck
MRK
|
+$12.9M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.19% |
| 2 | Consumer Discretionary | 9.21% |
| 3 | Financials | 8.21% |
| 4 | Healthcare | 8.07% |
| 5 | Industrials | 5.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1401
Generac Holdings
GNRC
$12.7B
| $62K | ﹤0.01% |
+616
| New | +$69.7K |
|
1402
Sprout Social
SPT
$600M
| $61.5K | ﹤0.01% |
+1,089
| New | +$63.9K |
|
1403
Verra Mobility
VRRM
$726M
| $61.4K | ﹤0.01% |
+4,437
| New | +$67.4K |
|
1404
Array Technologies
ARRY
$824M
| $60.8K | ﹤0.01% |
+3,144
| New | +$59.7K |
|
1405
Seres Therapeutics
MCRB
$46.6M
| $60.5K | ﹤0.01% |
+541
| New | +$72.5K |
|
1406
Cintas
CTAS
$82.1B
| $60.5K | ﹤0.01% |
+536
| New | +$58K |
|
|
EVRI
1407
DELISTED
Everi Holdings
EVRI
| $59.9K | ﹤0.01% |
+4,173
| New | +$69.3K |
|
1408
EPR Properties
EPR
$4.58B
| $59.5K | ﹤0.01% |
+1,577
| New | +$61.4K |
|
1409
Federal Agricultural Mortgage
AGM
$2.55B
| $59.2K | ﹤0.01% |
+525
| New | +$60.4K |
|
1410
Zeta Global
ZETA
$7.32B
| $59K | ﹤0.01% |
+7,218
| New | +$58.5K |
|
1411
Kforce
KFRC
$1.04B
| $58.8K | ﹤0.01% |
+1,073
| New | +$62K |
|
1412
Nkarta
NKTX
$167M
| $58.3K | ﹤0.01% |
+9,741
| New | +$98.3K |
|
1413
Valmont Industries
VMI
$9.52B
| $58.2K | ﹤0.01% |
+176
| New | +$55.8K |
|
|
RAD
1414
DELISTED
Rite Aid Corporation
RAD
| $58.1K | ﹤0.01% |
+17,404
| New | +$82.7K |
|
1415
Arcus Biosciences
RCUS
$3.66B
| $57.5K | ﹤0.01% |
+2,781
| New | +$76.5K |
|
1416
Innospec
IOSP
$2.31B
| $57.1K | ﹤0.01% |
+555
| New | +$56.3K |
|
1417
CALL
Quanta Services
PWR
$101B
| $57K | ﹤0.01% |
+400
| New | +$56.8K |
|
1418
Medifast
MED
$130M
| $57K | ﹤0.01% |
+494
| New | +$57.5K |
|
1419
Novanta
NOVT
$6.34B
| $56.9K | ﹤0.01% |
+419
| New | +$58.7K |
|
1420
Supernus Pharmaceuticals
SUPN
$2.73B
| $56.9K | ﹤0.01% |
+1,596
| New | +$55.5K |
|
1421
SPDR Gold Trust
GLD
$143B
| $56.8K | ﹤0.01% |
+335
| New | +$54K |
|
1422
LivePerson
LPSN
$33.6M
| $56.6K | ﹤0.01% |
+372
| New | +$59.6K |
|
1423
NVIDIA
NVDA
$5.27T
| $56.4K | ﹤0.01% |
+3,860
| New | +$56.6K |
|
|
MRSN
1424
DELISTED
Mersana Therapeutics
MRSN
| $56.1K | ﹤0.01% |
+383
| New | +$64.7K |
|
1425
Virgin Galactic
SPCE
$498M
| $55.8K | ﹤0.01% |
+802
| New | +$74.8K |
|
Similar funds
CC
SS
GW
WMSA
GC
WP
BWM
DI
Point72 Middle East FZE's Q4 2022 Portfolio in Review
Q4 2022 is the first quarter with a 13F filing on record for Point72 Middle East FZE, which disclosed 1,846 positions worth $2.28B. Its ten largest holdings account for 13% of the portfolio.
Its largest position is S&P Global: 49,387 shares worth $16.5M.
By sector, the portfolio is most concentrated in Technology at 10% of assets, followed by Consumer Discretionary and Financials.
- Point72 Middle East FZE's largest Q4 2022 buy was S&P Global: 49,387 shares worth $16.5M.
- Point72 Middle East FZE's ten largest holdings make up 13% of its $2.28B portfolio in Q4 2022.
- Point72 Middle East FZE disclosed 1,846 positions in Q4 2022, its first 13F filing on record.
Based on Point72 Middle East FZE's 13F filing for Q4 2022, filed 15 Feb 2023.